Financings In Brief
This article was originally published in The Gray Sheet
Executive Summary
Devicor Medical Products gets $250 million for acquisitions: Start-up seeks device acquisition to serve as a platform for growth, supported by a commitment for up to $250 million in financing from private equity firm and partner GTCR Golder Rauner. Announced March 10, the start-up is headed by CEO Thomas Daulton, former Cardinal Health general manager of Interventional Specialties and MedSystems divisions. Pleasant Prairie, Wis.-based Devicor Medical Products is seeking to buy "established interventional medical device businesses that manufacture and sell products to clinicians in settings such as hospitals, surgery centers or ambulatory clinics," the firm states. Devicor expects to complete an initial purchase in the $150 million-$400 million price range this year, supported in part with debt financing; smaller deals likely would follow, according to the company
You may also be interested in...
J&J/Ethicon Endo-Surgery Weighs Breast Care Divestiture To Devicor
Devicor Medical Products is seeking a foothold in the device market with its proposed acquisition of Johnson & Johnson/Ethicon Endo-Surgery's breast care business, the company announced March 30
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.